This shift might be explained by the availability of therapeutic treatment options for renal crisis (angiotensin-converting enzyme inhibitors) [42] and ILD (immunosuppressants and anti-fibrotic agents) [49] but limited treatment options for cardiac involvement. Here, ACE is linked to interstitial lung disease.